219835-70-8

Upstream product

• 589-87-7 1,4-bromoiodobenzene 
• 106-37-6 1.4-dibromobenzene 
• 163630-09-9 tributyl ([2,2'-bipyridin]-6-yl)stannane 
• 10495-73-5 2-bromo-6-(pyridin-2-yl)pyridine 
• 5467-74-3 4-Bromophenylboronic acid 

Downstream Products

• 911828-99-4 pinacol [4-(2,2'-bipyridin-6-yl)phenyl]boronate 
• 1012323-26-0 9-benzyl-8-[4-(2,2'-bipyridine-6-yl)phenyl]adenine 
• 286459-48-1 6-(4-tri-n-butylstannylphenyl)-2,2'-bipyridine 

Relevant academic research and scientific papers

Iron catalyzed oxidative assembly of N-heteroaryl and aryl metal reagents using oxygen as an oxidant

An equivalent amount of N-heteroaryl and aryl Grignard or lithium reagents, after mediation by an equivalent of titanate, was facilely coupled to furnish N-heteroaryl-aryl compounds under the catalysis of FeCl3/TMEDA at ambient temperature using oxygen as an oxidant. Most of the common N-heteroaryls were all good candidates, and thus provided a general, green and pratical protocol for the flexible construction of various N-heteroaryl-aryl structures. This journal is

Organic thin film and method for manufacturing organic thin film, organic electroluminescence element, display device, illumination device, organic thin film solar cell, thin film transistor, and coating composition

The purpose of the present invention is to provide an organic thin film with which excellent electron injection performance can be obtained when used in an electron injection layer of an organic EL element, and a method for manufacturing the organic thin film. The present invention is an organic thin film containing at least a first material, which is an organic material having an acid dissociation constant pKa of 1 or greater, and a second material for transporting electrons. The first material comprises one or more materials selected from tertiary amines, phosphazene compounds, guanidine compounds, heterocyclic compounds having an amidine structure, a hydrocarbon compound having a ring structure, and ketone compounds.

BORON-CONTAINING COMPOUND

PROBLEM TO BE SOLVED: To provide a boron-containing compound suitable as an organic electronic device material such as an organic EL element material and an n-type semiconductor. SOLUTION: The present invention provides a boron-containing compound having a specific structure. SELECTED DRAWING: None COPYRIGHT: (C)2016,JPOandINPIT

Purines bearing phenanthroline or bipyridine ligands and their RuII complexes in position 8 as model compounds for electrochemical DNA labeling - Synthesis, crystal structure, electrochemistry, quantum chemical calculations, cytostatic and antiviral activity

A series of ethynyl- or (4-boronophenyl)bipyridines and -phenanthrolines were prepared as versatile building blocks for attachment of bidentate N-ligands to other molecules via cross-coupling reactions. Their complexation with Ru(bpy)2-Cl2 gave the corresponding RuII complexes. 9-Benzyladenine derivatives bearing the bipyridine or phenanthroline complexes in position 8, attached via a conjugate acetylene or phenylene linker were prepared by cross-coupling reactions of the ethynyl- or 4-boronophenylbipyridines and -phenanthrolines with 9-benzyl-8-bromoadenine. Their complexation with Ru(bpy)2Cl2 afforded the corresponding Ru complexes as model compounds for electrochemical DNA labeling. The same compounds were also prepared directly by cross-coupling of 9-benzyl-8-bromoadenine with Ru complexes of the alkynes and boronic acids. Both approaches are compared in terms of potential applications for labeling of nucleic acids. The crystal structures of two Ru complexes were determined by X-ray diffraction. The electrochemistry of the model purines bearing the phenanthroline or bipyridine ligands and the Ru complexes was studied by means of cyclic or square-wave voltammetry with carbon paste and mercury electrodes. The experimental redox potentials of the title compounds were compared with quantum chemical calculations. A very good agreement between experiment and theory was obtained, with a standard deviation of 0.13 V. It was shown that theoretical calculations can be of a limited predictive power for new Ru II complexes, though it was difficult to reproduce differences smaller than 0.05 V. Several compounds of this series exhibited a considerable cytostatic effect and activity against the hepatitis C virus (HCV). Wiley-VCH Verlag GmbH & Co. KGaA, 2007.